JON HALBERT - 26 Feb 2026 Form 4 Insider Report for Caris Life Sciences, Inc. (CAI)

Role
Director
Signature
/s/ J. Russel Denton, Attorney-in-Fact
Issuer symbol
CAI
Transactions as of
26 Feb 2026
Net transactions value
+$49,990
Form type
4
Filing time
27 Feb 2026, 18:08:30 UTC
Previous filing
17 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HALBERT JON Director C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING /s/ J. Russel Denton, Attorney-in-Fact 27 Feb 2026 0001189394

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CAI Common Stock Award $49,990 +2,492 +2.1% $20.06 118,621 26 Feb 2026 Direct F1
holding CAI Common Stock 625,000 26 Feb 2026 By LAH Investments, Ltd. F2, F3
holding CAI Common Stock 625,000 26 Feb 2026 By Family Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued in lieu of cash compensation for 2025 board retainer fees. Number of shares determined by dividing the cash retainer earned by the ten trading day average of the daily volume weighted average price per share through and including February 25, 2026.
F2 The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F3 The 1,250,000 shares previously reported as held indirectly by Ke'Ohana Ventures, LLC were distributed in kind to its members. 625,000 shares were distributed to the Jon and Linda Halbert Management Trust, and 625,000 shares were distributed to LAH Investments, Ltd.